Morbidity and Disability in Infection

Death is only part of what an infection costs. Morbidity captures the illness itself - acute symptoms, hospitalisation, and the chronic impairment and disability that infection can leave in its wake. From rheumatic heart disease after streptococcal infection to neurological and functional sequelae after viral illness, much of the burden of communicable disease falls on survivors, and measuring it requires counting states of ill-health and weighting their severity.

Definition

Morbidity is the frequency and impact of illness and its consequences in a population, encompassing acute disease, complications, and the chronic impairment or disability that infection can cause; in burden assessment it is captured as time lived in health states weighted by their severity.

Scope

The topic covers the measurement of non-fatal infectious-disease burden: incidence and prevalence of disease states, the acute and long-term sequelae of infection, and the disability weights used to express their severity on a common scale. It is a reference to how non-fatal impact is quantified, not disease-specific prognosis or guidance on managing complications.

Core questions

• How is the non-fatal impact of infection measured and made comparable across conditions?
• What are disability weights and how are they assigned to infectious disease states?
• How do acute infections translate into chronic impairment and long-term sequelae?
• Why can morbidity dominate the burden of infections that rarely kill?

Key concepts

• Incidence and prevalence of disease states
• Acute morbidity and complications
• Chronic sequelae of infection
• Disability weight
• Years lived with disability (YLD)
• Health-state severity
• Post-acute infection syndromes

Mechanisms

Non-fatal burden is built by enumerating the people living in defined disease states - the prevalence or incidence of an infection and its complications - and weighting each state by a disability weight between 0 (full health) and 1 (a state equivalent to death) that reflects its severity. Multiplying the time spent in a state by its weight yields years lived with disability, the non-fatal half of the disability-adjusted life year (Murray & Lopez, 2013). Infections contribute to this in two ways: through acute illness and through chronic sequelae that persist after the pathogen is cleared, such as cardiac, neurological, or post-acute syndromes; long-term symptom clusters after viral infection are a contemporary example of measured post-acute morbidity (Sudre et al., 2021).

Clinical relevance

Morbidity and disability measures describe the non-fatal footprint of infection across populations and inform how systems weigh conditions that disable without killing; they characterise group-level impact and are not a basis for individual prognosis or treatment choices.

Epidemiology

Global burden syntheses estimate years lived with disability for hundreds of conditions, showing that for many infections - and increasingly across the disease spectrum - non-fatal burden contributes a substantial and growing share of total health loss (Vos et al., 2020). Post-acute sequelae of recent epidemics have drawn renewed attention to long-term morbidity following infection (Sudre et al., 2021).

Evidence & guidelines

The Global Burden of Disease framework standardises the estimation of prevalence and disability weights for non-fatal outcomes (Vos et al., 2020; Murray & Lopez, 2013), and core epidemiology texts define morbidity measures and their relation to incidence and prevalence (Rothman, Greenland & Lash, 2008).

History

Burden assessment originally risked equating health loss with death alone; the introduction of disability weights and years lived with disability made the non-fatal consequences of disease commensurable with mortality and revealed how much of the burden of many infections lies in chronic sequelae rather than death (Murray & Lopez, 2013; Vos et al., 2020).

Debates

How should disability weights for infection states be derived?

Disability weights aggregate societal valuations of health states and have been revised across burden studies; debate continues over whose valuations they should reflect and how to weight complex or chronic post-infection states.

Key figures

• Christopher J. L. Murray
• Theo Vos
• Alan D. Lopez

Seminal works

• murray-2013
• vos-2020

Frequently asked questions

Can an infection that rarely kills still cause a large burden?

Yes. If an infection is common and leaves lasting impairment - through complications or chronic sequelae - the years lived with disability it generates can exceed its contribution to mortality, making morbidity the dominant component of its burden.

What is a disability weight?

It is a number between 0 and 1 representing the severity of a health state, where 0 is full health and 1 is a state judged equivalent to death. Time spent in a state multiplied by its weight gives years lived with disability.